NASDAQ : QDEL
QuidelOrtho Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 13.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 908.62M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 908.62M |
| Enterprise Value | 3.86B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 68.58M |
| Shares Outstanding | 68.58M |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 1.14% |
| Owned by Institutions (%) | 106.84% |
| Float | 61.16M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 12.04 |
| PS Ratio | 0.34 |
| Forward PS | 0.35 |
| PB Ratio | 0.51 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.44 |
| EV / EBITDA | 7.97 |
| EV / EBIT | 104.06 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.39 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.73 |
| Debt / EBITDA | 5.82 |
| Debt / FCF | n/a |
| Interest Coverage | 0.18 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -45.91% |
| Return on Assets (ROA) | 0.38% |
| Return on Invested Capital (ROIC) | 0.80% |
| Return on Capital Employed (ROCE) | 0.79% |
| Weighted Average Cost of Capital (WACC) | 6.00% |
| Revenue Per Employee | $411,415 |
| Profits Per Employee | -$161,292 |
| Employee Count | 6,500 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.46 |
Taxes
| Measure | Value |
|---|
| Income Tax | 18.40M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -52.58% |
| 50-Day Moving Average | 12.76 |
| 200-Day Moving Average | 16.26 |
| Relative Strength Index (RSI) | 51.07 |
| Average Volume (20 Days) | 2,281,448 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 12.99M |
| Short Previous Month | 14.95M |
| Short % of Shares Out | 18.94% |
| Short % of Float | 21.24% |
| Short Ratio (days to cover) | 6.25 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.67B |
| Gross Profit | 1.20B |
| Operating Income | 37.10M |
| Pretax Income | -1.03B |
| Net Income | -1.05B |
| EBITDA | 484.60M |
| EBIT | 37.10M |
| Loss Per Share | -$15.40 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 123.40M |
| Total Debt | 3.08B |
| Net Cash | -2.95B |
| Net Cash Per Share | -$43.05 |
| Equity (Book Value) | 1.77B |
| Book Value Per Share | 25.99 |
| Working Capital | 383.20M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -57.20M |
| Capital Expenditures | -154.00M |
| Depreciation & Amortization | 447.50M |
| Net Borrowing | 271.20M |
| Free Cash Flow | -211.20M |
| FCF Per Share | -$3.08 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.86% |
| Operating Margin | 1.39% |
| Pretax Margin | -38.52% |
| Profit Margin | -39.20% |
| EBITDA Margin | 18.12% |
| EBIT Margin | 1.39% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.89% |
| Shareholder Yield | -0.89% |
| Earnings Yield | -116.19% |
| FCF Yield | -23.24% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $14.67 |
| Price Target Difference | 10.72% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -0.66% |
| EPS Growth Forecast (3Y) | -5.78% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |